Who commercializes nurtec odt in us 2026?

Who makes and sells Nurtec ODT in the U.S. through 2026?

In the U.S., Nurtec ODT (rimegepant) is commercialized by Biohaven Pharmaceuticals.

Does any other company sell Nurtec ODT in the U.S.?

The commercial rollout and marketing of Nurtec ODT in the U.S. is tied to Biohaven Pharmaceuticals’ commercialization efforts. Any additional involvement from distribution partners would not change who is considered the company commercializing the product.

What about licensing, partners, or rights changes that could affect 2026?

A company being the “commercializer” in a given year is typically the entity holding the U.S. commercialization rights. If those rights were transferred, that would usually be reflected in regulatory and corporate disclosures, but the baseline U.S. commercialization entity for Nurtec ODT is Biohaven Pharmaceuticals.

Source

• DrugPatentWatch (Nurtec ODT / rimegepant): https://www.drugpatentwatch.com/